GSK and SK will release competing products of the shingles vaccine ‘Zostavax’

It is expected that competing products of the only herpes zoster vaccine ‘Zostavax’ will be launched.

According to the industry concerned on the 15^th, a multinational company ‘GSK’ and a domestic company ‘SK Chemicals’ are working on commercialization of each herpes zoster vaccine developing.

GSK has completed the Phase 3 clinical trial, which has been conducted for its herpes zoster vaccine ...